April 16, 2025: Experts Called To Testify at May 14th Hearing in Rybelsus Lawsuit Gastroparesis, or paralysis of the stomach, intestines, and gut, is one of the adverse reactions people are alleging after taking Rybelsus and other GLP-1s
Consider these factors across all potential sources: Regulatory status: 503A vs 503B vs FDA-registered manufacturer Inspection record: Form 483 history, Warning Letters, corrective actions Testing capabilities: In-house vs outsourced, scope of testing Manufacturing technology: Manual vs automated filling systems Corporate history: Parent companies, legal issues, leadership background Product specifications: Concentrations, vial sizes, beyond use dating Formulation approach: Standalone vs combination products Documentation: Certificates of analysis availability, batch testing results BPI Labs scores well on manufacturing technology, testing capabilities, and production scale
Start your intake FDA Regulation and Why GLP-1 Requires a Prescription The FDA classifies GLP-1 receptor agonists as prescription medications because they are potent hormonal drugs affecting blood glucose, appetite signaling, and metabolic rate
Saikia M, Holter MM, Donahue LR, et al
